这是一篇来自已证抗体库的有关
人类 ORAI3的综述,是根据6篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合ORAI3 抗体。
ORAI3 同义词: TMEM142C; protein orai-3; transmembrane protein 142C
ProSci
兔 多克隆 | | ProSci ORAI3抗体(ProSci Incorporated, 4117)被用于被用于免疫印迹在人类样品上浓度为1:500 (图 1e). Nat Commun (2017) ncbi |
兔 多克隆 | - 免疫细胞化学; 小鼠; 1:200; 表 1
- 免疫印迹; 小鼠; 1:1000; 表 1
| ProSci ORAI3抗体(ProSci, 4117)被用于被用于免疫细胞化学在小鼠样品上浓度为1:200 (表 1) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (表 1). Front Physiol (2015) ncbi |
兔 多克隆 | | ProSci ORAI3抗体(ProSci, 4215)被用于被用于免疫沉淀在大鼠样品上浓度为20 ug. Cardiovasc Res (2015) ncbi |
兔 多克隆 | | ProSci ORAI3抗体(Prosci Inc, 4117)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Cardiovasc Res (2015) ncbi |
兔 多克隆 | | ProSci ORAI3抗体(ProSci, 4215)被用于被用于免疫沉淀在人类样品上. J Physiol (2013) ncbi |
兔 多克隆 | - 免疫组化-冰冻切片; 大鼠; 3 ug/ml
- 免疫印迹; 大鼠; 1 ug/ml
| ProSci ORAI3抗体(ProSci, 4117)被用于被用于免疫组化-冰冻切片在大鼠样品上浓度为3 ug/ml 和 被用于免疫印迹在大鼠样品上浓度为1 ug/ml. Eur J Pharmacol (2011) ncbi |
西格玛奥德里奇
兔 多克隆 | | 西格玛奥德里奇 ORAI3抗体(Sigma-Aldrich, HPA015022)被用于被用于免疫印迹在人类样品上浓度为1:200 (图 3). Stem Cells Dev (2016) ncbi |
Zeng B, Chen G, Garcia Vaz E, Bhandari S, Daskoulidou N, Berglund L,
et al. ORAI channels are critical for receptor-mediated endocytosis of albumin. Nat Commun. 2017;8:1920
pubmed 出版商
Zuccolo E, Bottino C, Diofano F, Poletto V, Codazzi A, Mannarino S,
et al. Constitutive Store-Operated Ca(2+) Entry Leads to Enhanced Nitric Oxide Production and Proliferation in Infantile Hemangioma-Derived Endothelial Colony-Forming Cells. Stem Cells Dev. 2016;25:301-19
pubmed 出版商
Liu J, Xin L, Benson V, Allen D, Ju Y. Store-operated calcium entry and the localization of STIM1 and Orai1 proteins in isolated mouse sinoatrial node cells. Front Physiol. 2015;6:69
pubmed 出版商
Saliba Y, Keck M, Marchand A, Atassi F, Ouillé A, Cazorla O,
et al. Emergence of Orai3 activity during cardiac hypertrophy. Cardiovasc Res. 2015;105:248-59
pubmed 出版商
Thompson J, Shuttleworth T. Molecular basis of activation of the arachidonate-regulated Ca2+ (ARC) channel, a store-independent Orai channel, by plasma membrane STIM1. J Physiol. 2013;591:3507-23
pubmed 出版商
Wolkowicz P, Huang J, Umeda P, Sharifov O, TABENGWA E, Halloran B,
et al. Pharmacological evidence for Orai channel activation as a source of cardiac abnormal automaticity. Eur J Pharmacol. 2011;668:208-16
pubmed 出版商